| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningioma | 10 | 2023 | 296 | 5.100 |
Why?
|
| Meningeal Neoplasms | 9 | 2023 | 457 | 4.570 |
Why?
|
| Neurosurgery | 5 | 2022 | 119 | 2.040 |
Why?
|
| Spinal Fusion | 8 | 2013 | 155 | 1.330 |
Why?
|
| Neurosurgical Procedures | 11 | 2022 | 639 | 1.300 |
Why?
|
| Brain Neoplasms | 12 | 2022 | 4995 | 1.160 |
Why?
|
| Bone Screws | 6 | 2013 | 88 | 1.130 |
Why?
|
| Craniotomy | 3 | 2022 | 313 | 0.900 |
Why?
|
| Skull Base Neoplasms | 2 | 2021 | 333 | 0.850 |
Why?
|
| Virtual Reality | 1 | 2022 | 37 | 0.800 |
Why?
|
| Supratentorial Neoplasms | 1 | 2022 | 79 | 0.780 |
Why?
|
| Job Application | 1 | 2021 | 19 | 0.780 |
Why?
|
| Internship and Residency | 3 | 2022 | 1476 | 0.760 |
Why?
|
| Lumbar Vertebrae | 2 | 2013 | 250 | 0.760 |
Why?
|
| Epidermal Cyst | 1 | 2021 | 46 | 0.740 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2021 | 45 | 0.740 |
Why?
|
| Ependymoma | 1 | 2022 | 262 | 0.710 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 32 | 0.690 |
Why?
|
| Optic Nerve Glioma | 1 | 2019 | 31 | 0.660 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2019 | 37 | 0.650 |
Why?
|
| Faculty, Medical | 2 | 2021 | 318 | 0.630 |
Why?
|
| Cerebellar Neoplasms | 2 | 2021 | 469 | 0.600 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2017 | 19 | 0.590 |
Why?
|
| Erdheim-Chester Disease | 1 | 2017 | 54 | 0.590 |
Why?
|
| Third Ventricle | 1 | 2017 | 42 | 0.580 |
Why?
|
| Hemangioma, Cavernous | 1 | 2017 | 29 | 0.580 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2017 | 81 | 0.560 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 312 | 0.560 |
Why?
|
| Evoked Potentials, Motor | 2 | 2013 | 59 | 0.530 |
Why?
|
| Odontoid Process | 2 | 2012 | 13 | 0.530 |
Why?
|
| Monitoring, Intraoperative | 3 | 2016 | 269 | 0.520 |
Why?
|
| Repressor Proteins | 2 | 2022 | 1699 | 0.520 |
Why?
|
| Decompression, Surgical | 2 | 2015 | 148 | 0.510 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 781 | 0.500 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2023 | 10257 | 0.490 |
Why?
|
| Hydrocephalus | 1 | 2017 | 239 | 0.490 |
Why?
|
| Endoscopy | 2 | 2021 | 491 | 0.470 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2019 | 620 | 0.470 |
Why?
|
| Astrocytoma | 2 | 2021 | 328 | 0.460 |
Why?
|
| Humans | 65 | 2023 | 270843 | 0.460 |
Why?
|
| Cerebral Revascularization | 1 | 2013 | 24 | 0.450 |
Why?
|
| Spondylolisthesis | 1 | 2013 | 8 | 0.450 |
Why?
|
| Lipomatosis | 1 | 2013 | 23 | 0.450 |
Why?
|
| Globus Pallidus | 1 | 2013 | 70 | 0.450 |
Why?
|
| Epidural Space | 1 | 2013 | 43 | 0.440 |
Why?
|
| Sacrococcygeal Region | 1 | 2013 | 37 | 0.440 |
Why?
|
| Temporal Arteries | 1 | 2013 | 43 | 0.440 |
Why?
|
| Remission, Spontaneous | 1 | 2013 | 121 | 0.440 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 70 | 0.440 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2013 | 38 | 0.440 |
Why?
|
| Skull Base | 1 | 2014 | 220 | 0.430 |
Why?
|
| Internal Fixators | 1 | 2012 | 16 | 0.430 |
Why?
|
| Middle Cerebral Artery | 1 | 2013 | 90 | 0.430 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2012 | 63 | 0.430 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 79 | 0.420 |
Why?
|
| Spinal Nerve Roots | 1 | 2012 | 66 | 0.420 |
Why?
|
| Dystonic Disorders | 1 | 2013 | 82 | 0.420 |
Why?
|
| Radiosurgery | 1 | 2022 | 1369 | 0.420 |
Why?
|
| Atlanto-Axial Joint | 1 | 2012 | 25 | 0.410 |
Why?
|
| Deep Brain Stimulation | 2 | 2014 | 379 | 0.400 |
Why?
|
| Posters as Topic | 1 | 2011 | 8 | 0.400 |
Why?
|
| Osteoblastoma | 1 | 2011 | 15 | 0.400 |
Why?
|
| Spinal Diseases | 1 | 2012 | 129 | 0.390 |
Why?
|
| Publications | 1 | 2011 | 56 | 0.380 |
Why?
|
| Fracture Fixation | 1 | 2011 | 36 | 0.380 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 244 | 0.380 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2010 | 5 | 0.380 |
Why?
|
| Peer Review, Research | 1 | 2011 | 73 | 0.370 |
Why?
|
| Glioblastoma | 5 | 2022 | 1844 | 0.370 |
Why?
|
| Brain Ischemia | 1 | 2013 | 302 | 0.370 |
Why?
|
| Infratentorial Neoplasms | 1 | 2010 | 46 | 0.360 |
Why?
|
| Comorbidity | 2 | 2014 | 2454 | 0.360 |
Why?
|
| Congenital Abnormalities | 1 | 2013 | 271 | 0.360 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 193 | 0.350 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 50 | 0.350 |
Why?
|
| Down Syndrome | 1 | 2012 | 228 | 0.340 |
Why?
|
| Male | 36 | 2023 | 127630 | 0.340 |
Why?
|
| Female | 35 | 2023 | 147292 | 0.340 |
Why?
|
| Congresses as Topic | 1 | 2011 | 314 | 0.340 |
Why?
|
| Neuralgia | 1 | 2012 | 254 | 0.330 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5930 | 0.330 |
Why?
|
| Skull | 1 | 2010 | 250 | 0.320 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 308 | 0.310 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 398 | 0.310 |
Why?
|
| Superior Sagittal Sinus | 2 | 2021 | 4 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2021 | 7738 | 0.290 |
Why?
|
| Child | 18 | 2023 | 30200 | 0.290 |
Why?
|
| Adult | 23 | 2023 | 80709 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2019 | 7962 | 0.290 |
Why?
|
| Mutation | 6 | 2023 | 15642 | 0.270 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 656 | 0.270 |
Why?
|
| Prognosis | 9 | 2022 | 22249 | 0.260 |
Why?
|
| Radiotherapy | 2 | 2019 | 1852 | 0.250 |
Why?
|
| Adolescent | 17 | 2020 | 32336 | 0.240 |
Why?
|
| Follow-Up Studies | 10 | 2020 | 15198 | 0.240 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 647 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2021 | 949 | 0.230 |
Why?
|
| Xenobiotics | 1 | 2023 | 42 | 0.220 |
Why?
|
| Cholesteatoma | 1 | 2023 | 6 | 0.220 |
Why?
|
| Osteosarcoma | 1 | 2010 | 950 | 0.220 |
Why?
|
| Cholesteatoma, Middle Ear | 1 | 2023 | 9 | 0.220 |
Why?
|
| Otologic Surgical Procedures | 1 | 2023 | 35 | 0.210 |
Why?
|
| Middle Aged | 14 | 2020 | 89535 | 0.210 |
Why?
|
| Glucuronosyltransferase | 1 | 2023 | 109 | 0.210 |
Why?
|
| Postoperative Complications | 4 | 2015 | 5838 | 0.210 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2022 | 104 | 0.210 |
Why?
|
| Cochlear Implantation | 1 | 2023 | 46 | 0.210 |
Why?
|
| Communication Barriers | 1 | 2022 | 54 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2010 | 1377 | 0.200 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 93 | 0.200 |
Why?
|
| Scoliosis | 2 | 2013 | 151 | 0.200 |
Why?
|
| Online Systems | 1 | 2021 | 27 | 0.200 |
Why?
|
| Child, Preschool | 8 | 2014 | 16792 | 0.200 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 10627 | 0.190 |
Why?
|
| Cerebellopontine Angle | 1 | 2021 | 12 | 0.190 |
Why?
|
| Phlebography | 1 | 2021 | 79 | 0.190 |
Why?
|
| Workload | 1 | 2022 | 203 | 0.190 |
Why?
|
| Carotid Artery, Internal | 1 | 2021 | 83 | 0.190 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2022 | 278 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2023 | 491 | 0.180 |
Why?
|
| Retrospective Studies | 15 | 2023 | 39512 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2022 | 1263 | 0.180 |
Why?
|
| Angiofibroma | 1 | 2019 | 17 | 0.180 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 232 | 0.180 |
Why?
|
| Plant Extracts | 1 | 2022 | 226 | 0.170 |
Why?
|
| Glioma | 2 | 2022 | 2001 | 0.170 |
Why?
|
| Infant | 7 | 2014 | 13818 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 116 | 0.170 |
Why?
|
| Aged | 12 | 2022 | 72902 | 0.170 |
Why?
|
| Hospitals | 1 | 2022 | 494 | 0.160 |
Why?
|
| Somatosensory Cortex | 1 | 2019 | 69 | 0.160 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 125 | 0.160 |
Why?
|
| Intralaminar Thalamic Nuclei | 1 | 2017 | 7 | 0.150 |
Why?
|
| Young Adult | 9 | 2020 | 22140 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 139 | 0.150 |
Why?
|
| Therapies, Investigational | 1 | 2018 | 63 | 0.150 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 948 | 0.150 |
Why?
|
| Sex Factors | 2 | 2014 | 2217 | 0.150 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2019 | 326 | 0.140 |
Why?
|
| Cohort Studies | 4 | 2020 | 9487 | 0.140 |
Why?
|
| Vision Disorders | 1 | 2019 | 243 | 0.140 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 502 | 0.140 |
Why?
|
| Headache | 1 | 2017 | 165 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2019 | 513 | 0.140 |
Why?
|
| Ganglioglioma | 1 | 2016 | 41 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 709 | 0.130 |
Why?
|
| Venous Thromboembolism | 1 | 2021 | 378 | 0.130 |
Why?
|
| Incidence | 4 | 2019 | 5904 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 1699 | 0.130 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 1538 | 0.130 |
Why?
|
| Cubital Tunnel Syndrome | 1 | 2015 | 6 | 0.130 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 126 | 0.130 |
Why?
|
| Health Personnel | 1 | 2020 | 649 | 0.120 |
Why?
|
| Age Factors | 3 | 2014 | 5506 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2016 | 202 | 0.120 |
Why?
|
| Treatment Outcome | 10 | 2021 | 34238 | 0.120 |
Why?
|
| Inpatients | 1 | 2019 | 700 | 0.120 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 198 | 0.120 |
Why?
|
| Telemedicine | 1 | 2020 | 536 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 537 | 0.120 |
Why?
|
| Disease Management | 1 | 2019 | 1106 | 0.110 |
Why?
|
| Ilium | 1 | 2013 | 55 | 0.110 |
Why?
|
| Smoking | 1 | 2023 | 2525 | 0.110 |
Why?
|
| Muscle Relaxants, Central | 1 | 2013 | 36 | 0.110 |
Why?
|
| Frontal Sinus | 1 | 2013 | 14 | 0.110 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2013 | 32 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2019 | 2117 | 0.110 |
Why?
|
| Professional Practice | 1 | 2013 | 83 | 0.110 |
Why?
|
| Braces | 1 | 2013 | 12 | 0.110 |
Why?
|
| Brain Stem | 1 | 2014 | 177 | 0.110 |
Why?
|
| Meningocele | 1 | 2013 | 20 | 0.110 |
Why?
|
| Encephalocele | 1 | 2013 | 57 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2013 | 251 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 128 | 0.110 |
Why?
|
| Wounds, Gunshot | 1 | 2014 | 109 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2014 | 240 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 135 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 130 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 185 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 414 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2017 | 1410 | 0.110 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 367 | 0.100 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 550 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2013 | 89 | 0.100 |
Why?
|
| Genomics | 1 | 2023 | 2819 | 0.100 |
Why?
|
| Zygapophyseal Joint | 1 | 2012 | 15 | 0.100 |
Why?
|
| Pineal Gland | 1 | 2012 | 51 | 0.100 |
Why?
|
| Orthotic Devices | 1 | 2012 | 21 | 0.100 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 30813 | 0.100 |
Why?
|
| Germinoma | 1 | 2012 | 85 | 0.100 |
Why?
|
| Cell Line | 1 | 2019 | 5132 | 0.100 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2011 | 4 | 0.100 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 531 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2022 | 2736 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 3 | 2016 | 1508 | 0.100 |
Why?
|
| Cervical Vertebrae | 1 | 2012 | 217 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 247 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 2341 | 0.100 |
Why?
|
| Skull Fractures | 1 | 2011 | 48 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2022 | 68 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 589 | 0.090 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2012 | 148 | 0.090 |
Why?
|
| Research Design | 1 | 2018 | 1598 | 0.090 |
Why?
|
| Seizures | 2 | 2013 | 999 | 0.090 |
Why?
|
| Malformations of Cortical Development | 1 | 2010 | 56 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2012 | 143 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 2217 | 0.090 |
Why?
|
| Disease Progression | 2 | 2019 | 6891 | 0.090 |
Why?
|
| Postoperative Care | 2 | 2012 | 752 | 0.090 |
Why?
|
| Epilepsies, Partial | 1 | 2010 | 114 | 0.090 |
Why?
|
| Stents | 1 | 2016 | 1152 | 0.080 |
Why?
|
| Schools, Medical | 1 | 2010 | 137 | 0.080 |
Why?
|
| Clinical Clerkship | 1 | 2010 | 106 | 0.080 |
Why?
|
| Liver Transplantation | 3 | 2006 | 1162 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2022 | 530 | 0.080 |
Why?
|
| United States | 3 | 2021 | 16339 | 0.080 |
Why?
|
| Purkinje Cells | 2 | 2006 | 154 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2014 | 714 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1142 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2013 | 1859 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5242 | 0.070 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 343 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 3836 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 4386 | 0.070 |
Why?
|
| Propionates | 1 | 2006 | 76 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1018 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2010 | 727 | 0.070 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2006 | 104 | 0.070 |
Why?
|
| Pregnancy | 1 | 2019 | 7825 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 5031 | 0.060 |
Why?
|
| Biopsy | 1 | 2013 | 3490 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2364 | 0.060 |
Why?
|
| Survival Rate | 3 | 2018 | 12451 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2011 | 1399 | 0.060 |
Why?
|
| Nervous System | 1 | 2005 | 172 | 0.060 |
Why?
|
| Ataxia | 1 | 2006 | 178 | 0.060 |
Why?
|
| Liver Failure, Acute | 1 | 2005 | 90 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2005 | 152 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2005 | 139 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1584 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 270 | 0.050 |
Why?
|
| Mastoid | 1 | 2023 | 28 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2014 | 8566 | 0.050 |
Why?
|
| Ear Canal | 1 | 2023 | 30 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2010 | 4462 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 5116 | 0.050 |
Why?
|
| Injections | 1 | 2021 | 289 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2995 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 5239 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 9010 | 0.040 |
Why?
|
| Time Factors | 1 | 2014 | 13266 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2005 | 1615 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2019 | 23 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2005 | 839 | 0.040 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 63 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 884 | 0.040 |
Why?
|
| Karnofsky Performance Status | 1 | 2019 | 176 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 312 | 0.040 |
Why?
|
| Reoperation | 2 | 2015 | 1449 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2018 | 180 | 0.040 |
Why?
|
| Risk Factors | 2 | 2013 | 18267 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2019 | 259 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 474 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 547 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 2015 | 21 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2018 | 679 | 0.030 |
Why?
|
| Adie Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2016 | 594 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 1496 | 0.030 |
Why?
|
| Lordosis | 1 | 2013 | 6 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 3385 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 2722 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 957 | 0.030 |
Why?
|
| Kyphosis | 1 | 2013 | 44 | 0.030 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 11 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2013 | 52 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 415 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2014 | 100 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 122 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2013 | 56 | 0.030 |
Why?
|
| Intracranial Hypertension | 1 | 2014 | 123 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2013 | 267 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 1433 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2013 | 234 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 450 | 0.030 |
Why?
|
| Meningitis, Bacterial | 1 | 2013 | 93 | 0.030 |
Why?
|
| Longitudinal Ligaments | 1 | 2012 | 6 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2319 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 589 | 0.030 |
Why?
|
| Fracture Healing | 1 | 2012 | 41 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 3109 | 0.030 |
Why?
|
| Motorcycles | 1 | 2011 | 8 | 0.020 |
Why?
|
| Benchmarking | 1 | 2013 | 289 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2016 | 937 | 0.020 |
Why?
|
| Fractures, Spontaneous | 1 | 2012 | 85 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2005 | 5362 | 0.020 |
Why?
|
| Vacuum | 1 | 2010 | 42 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 122 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 834 | 0.020 |
Why?
|
| Syringes | 1 | 2010 | 43 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2010 | 196 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 4721 | 0.020 |
Why?
|
| Mentors | 1 | 2010 | 217 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 2943 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 640 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 6196 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 9324 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 4895 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 3522 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 2052 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 628 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2006 | 182 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 102 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 13310 | 0.020 |
Why?
|
| Cross Circulation | 1 | 2005 | 5 | 0.020 |
Why?
|
| Hemoperfusion | 1 | 2005 | 5 | 0.020 |
Why?
|
| Liver, Artificial | 1 | 2005 | 8 | 0.020 |
Why?
|
| Dialysis | 1 | 2005 | 23 | 0.020 |
Why?
|
| Ataxins | 1 | 2005 | 90 | 0.020 |
Why?
|
| Hemodiafiltration | 1 | 2005 | 19 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 2005 | 59 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 2005 | 45 | 0.020 |
Why?
|
| Primates | 1 | 2005 | 132 | 0.020 |
Why?
|
| Ataxin-1 | 1 | 2005 | 147 | 0.020 |
Why?
|
| Students, Medical | 1 | 2010 | 430 | 0.020 |
Why?
|
| Liver Failure | 1 | 2005 | 142 | 0.010 |
Why?
|
| Perfusion | 1 | 2005 | 297 | 0.010 |
Why?
|
| Pediatrics | 1 | 2013 | 1189 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 252 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2005 | 353 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 1091 | 0.010 |
Why?
|
| Graft Survival | 1 | 2006 | 1094 | 0.010 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 237 | 0.010 |
Why?
|
| Proteome | 1 | 2006 | 577 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1506 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2005 | 612 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 856 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 468 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1610 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2005 | 846 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 3096 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2114 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 4194 | 0.010 |
Why?
|
| Computational Biology | 1 | 2006 | 1299 | 0.010 |
Why?
|
| Neurons | 1 | 2010 | 2386 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 6127 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 2944 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2005 | 1046 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2005 | 970 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 4245 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5670 | 0.010 |
Why?
|
| Registries | 1 | 2005 | 2288 | 0.010 |
Why?
|
| Animals | 3 | 2006 | 61014 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 4911 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 35331 | 0.000 |
Why?
|